Eisai Clinical Trials

A Multicenter, Open-label, Single-arm, Phase 4 Study to Evaluate the Efficacy and Safety of Filgotinib in Korean Patients With Rheumatoid Arthritis

GS6034-M082-401

Study Overview

GS6034
filgotinib
NCT06625242
Oct 2024 - Feb 2026
Rheumatoid Arthritis
Percentage of Participants Achieving ACR20 Response at Week 12

  • Males and females (19 years and older)

  • Completed

  • Phase 4

  • Korea, Republic of

Clinical Trial Documents

Clinical Study Report Synopsis

Download PDF

Plain Language Protocol Synopsis (PLPS)

No download available

Plain Language Summary of Results (PLS)

No download available

Publication reference citation

N/A

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

CSDR Sharing is not available for this study.

CSDR Availability
Clinical Trial Data

Redacted documents may be available upon request for this study.

Document type Availability
Protocol
SAP
Sample CRF
Full CSR